- Diethyl dipropylmalonate (CAS No. 6065-63-0) for Valproic acid and it’s salts)
- Diethyl ethyl (1-methylbutyl)malonate( for Pentobarbital, Thiopental sodium)
- Diethyl isopropylmalonate (for pharmaceuticals and others)
- Pyrogallolaldehyde (for Benzerazide)
- Benzhydrylamine (for Pharmaceuticals)
- 1-Benzhydrylazetidin-3-ol (for Pharmaceuticals)
- Azetidin-3-ol hydrogenchloride (for Pharmaceuticals)
- 1-(2-Hydroxyphenyl)-3-phenylpropan-1-one ( for Propafenone)
- Ritalinic acid (for Methylphenidate)
- d-Ritallnic acid HCL (for Dexmethylphenidate)
- (1R,2S)-1Phenyl-2-(pyrrolldin1-yl)propan-1-ol CAS no. 127641-25-2) for Efavirenz
- (S)-3-(Methylamino)-1-(2-thienyl)propan-1-ol (for Duloxetine)
- Menthadienol ( CAS no. 22972-51-6) for CBD and Dronabinol
- Olivetol ( CAS no. 500-66-3) for cbd Dronabinol
- Methyl Olivetolate (CAS no 58016-28-7) for CBD and Dronabinol
- Ethyl Olivetolate (CAS no. 38862-65-6) for CBD and Dronabinol
- PROSTAGLANDIN INTERMEDIATES
- “(-)COD (-)-Corey Lactone Diol Purity: ≥99.0 %”
- “(+)COD (+)-Corey Lactone Diol Purity: ≥99.0 %”
- “BCOD (-)-Corey Lactone Benzoate Purity: ≥99.0 %”
- “BPCOD (-)-Corey Lactone p-Phenyl Benzoate Purity: ≥99.0 %”
- “TPPB (4-carboxybutyl)triphenylphosphonium bromide Purity: ≥99.0 %”
- “BMP Dimethyl(2-oxo-4-phenylbutyl)phosphonate Purity: ≥94.0 %”
- BIMATOPROST AND LATANOPROST INTERMEDIATES
- “BMP Dimethyl(2-oxo-4-phenylbutyl)phosphonate Purity: ≥94.0 %”
- “BP-2 (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4- [(1E,3R)-3-hydroxy-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- “LT-DI (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4- [(3R)-3-hydroxy-5-phenylpentyl]-2H-cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- “BM-BPH [1,1′-Biphenyl]-4-carboxylic acid, (3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3- hydroxy-5-phenyl-1-penten-1-yl]-2-oxo-2H- cyclopenta[b]furan-5-yl ester Purity: ≥99.0 %”
- “BM-BH (3aR,4R,5R,6aS)-5-(benzoyloxy)hexahydro-4-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1- yl]-2H-cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- “LT-TRI (3aR, 4R,5R,6aS)-hexahydro-4-[(3R)-3- hydroxy-5-phenylpentyl]-2H-cyclopenta[b] furan-2,5-diol Purity: ≥99.0 %”
- “LT-Acid (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept- 5-enoic acid Purity: ≥98.0 %”
- “LT-BPK [1,1′-Biphenyl]-4-carboxylic acid (3aR,4R, 5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo -5-phenyl-1-pentenyl]-2H- yclopenta[b] furan-5-yl ester Purity: ≥99.0 %”
- “LT-BK (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-5-phenyl-1-pentenyl]-2H- cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- DINOPROSTONE INTERMEDIATES
- “DN-BPK [1,1′-Biphenyl]-4-carboxylic acid (3aR,4R, 5R, 6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-1-octenyl]-2H-cyclopenta[b]furan-5-yl ester Purity: ≥99.0 %”
- “DN-BK (3aR,4R,5R,6aS)-2-oxo-4-((E)-3-oxooct-1-en-1-yl)hexahydro-2H-cyclopenta[b] furan-5-yl benzoate Purity: ≥99.0 %”
- “DN-BT (3aR,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E, 3S)-3-[[(1,1-dimethylethyl)dimethylsilyl] oxy]-1-octen-1-yl]hexahydro-2H-cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- “DNP Dimethyl (2-oxoheptyl)phosphonate Purity: ≥92.0 %”
- “DN-BPH [1,1′-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2-oxo- Hcyclopenta[b]furan-5-yl ester Purity: ≥98.0 %”
- “DN-DI (Corey PG-Lactone Diol) (3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2Hcyclopenta[b]furan-2-one Purity: ≥98.0 %”
- LUBIPROSTONE INTERMEDIATES
- “LB-BPK [1,1′-Biphenyl]-4-carboxylic acid [3aR- [3aa,4a(E),5b,6aa]]-4-(4,4-difluoro-3-oxo-1-octenyl)hexahydro-2-oxo-2Hcyclopenta[b]furan-5-ylester Purity: ≥98.0 %”
- “LBP Dimethyl(3,3-difluoro-2-oxoheptyl) phosphonate Purity: ≥97.0 %”
- ILOPROST INTERMEDIATES
- “IL-THTB [3aS-(3aa,4a,5b,6aa)]-4-[[[(tert-Butyl) dimethylsilyl]oxy]methyl]-5-[(tetrahydro-2H-pyran-2-yl)oxy]hexahydro-2(1H)-pentalenone Purity: ≥95.0 %”
- TAFLUPROST INTERMEDIATES
- “TF-DI (3aR,4R,5R,6aS)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H- cyclopenta[b]furan-2,5-diol Purity: ≥98.0 %”
- “TF-HF (3aR,4R,5R,6aS)-4-[(1E)-3,3-difluoro-4- phenoxy-1-buten-1-yl]hexahydro-5-hydroxy-2H-Cyclopenta[b]furan-2-one Purity: ≥98.0 %”
- “TF-BF (3aR,4R,5R,6aS)-5-(benzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl] hexahydro-2H-Cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- “TF-BPF (3aR,4R,5R,6aS)-5-(p-phenylbenzoyloxy)-4-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]hexahydro-2H-cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- “TI-BPK [3aR-[3a,4(E),5,6a]]-[1,1′-Biphenyl]-4- carboxylic acid, hexahydro-2-oxo-4-[3-oxo-4-(3-thienyloxy)-1-butenyl]-2H-cyclopenta[b]furan-5-yl ester Purity: ≥98.0 %”
- “TIP Dimethyl [2-oxo-3-(3-thienyloxy)-propyl] phosphonate Purity: ≥93.0 %”
- TRAVOPROST INTERMEDIATES
- “TV-BPK [1,1′-Biphenyl]-4-carboxylicacid (3aR,4R, 5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo -4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-5-yl ester Purity: ≥99.0 %”
- “TV-BK (3aR,4R,5R,6aS)-5-(Benzoyloxy) hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopenta[b]furan-2-one Purity: ≥99.0 %”
- “TVP Dimethyl[2-Oxo-3-(3-trifluoromethyl-phenoxy)-propyl]phosphonate Purity: ≥93.0 %”
- “TV-DI (3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-[(1E,3R)-3-hydroxy-4-(3-trifluoromethyl)phenoxy-1-butenyl]-2H-cyclopenta[b]furan-2-onePurity: ≥99.0 %”
- “TV-TRI (3aR,4R,5R,6aS)-hexahydro-4-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-2H-cyclopentab]furan-2,5-diol Purity: ≥99.0%”
- ETIPROSTON AND TAFLUPROST INTERMEDIATES
- “ETP Dimethyl(3-phenoxy-2-oxopropyl) phosphonate Purity: ≥95.0 %”
- ENPROSTONE INTERMEDIATES
- “EN-2 [1,1′-Biphenyl]-4-carboxylic acid hexahydro-2-oxo-4-[2-[2-(phenoxy methyl)-1,3-dioxolan-2-yl]ethenyl]-2H-
- cyclopenta[b]furan-5-yl ester Purity: ≥98.0 %”
- “EN-CPN 16-phenoxy tetranor PGF2α cyclopropyl methyl amide Purity: ≥98.0 %”
- Diethyl(3-pyridyl)borane Purity≥99.0%
- “F-TEDA-BF4 (Selectfluor) Purity≥96.0%”
- “4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidine”
- Benzyl-DBU-Chloride
- “Synfluor reagent N,N’- Purity≥96.0%”
- N-Fluorobenzenesulfonimide (NFSI)
- “1-Fluoro-4-methyl-1,4-diazoniabicyclo [2.2.2]Octane-tetrafluoroborate Purity≥96.0%”
- “Trifluoromethyl Trimethylsilane Ruppert Reagent Purity≥98.0%”
- “2,3-Difluorobenzaldehyde Purity≥98.0%”
- “2,3-Difluorophenylacetic acid Purity≥98.0%”
- “5-(trifluoromethyl)-2-Thiophenecarboxylic acid Purity≥99.0%”
- DOLUTEGRAVIR INTERMEDIATES
- 1-(2,3-dihydroxypropyl)-1,4-dihydro-4-oxo-3 -(phenylmethoxy)-2-Pyridinecarboxylic acid methyl ester
- PRANLUKAST INTERMEDIATES
- “3-Amino-2-hydroxyacetophenone Purity ≥ 99.0%”
- “4-(4-Phenylbutoxy)benzoic acid Purity ≥ 99.0%”
- “N-(3-acetyl-2-hydroxyphenyl)-4-(4-phenylbutoxy)benzamide”
- “N-(2-cyano-4-oxo-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide Purity ≥ 99.0%”
- “8-Amino-4-oxo-2-(tetrazol-5-yl)-4H-1-Benzopyran Hydrochloride Purity ≥ 99.0%”
- TICAGRELOR INTERMEDIATES
- “N-[(3aS,4R,6S,6aR)-Tetrahydro-6-hydroxy-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]carbamicacid phenylmethyl ester”
- “2-[[(3aR,4S,6R,6aS)-6-aminotetra hydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol”
- 4,6-dichloro-2-propylthio-pyrimidine -5-amine
- (1R,2S)-2-(3,4-difluorophenyl)- Cyclopropanamine
- MACITENTAN INTERMEDIATES
- 5-Bromo-2-chloropyrimidine
- 5-(4-bromophenyl)-4,6-dichloropyrimidine
- Sulfamide, N-propyl-,sodium salt (1:1)
- RAMELTEON INTERMEDIATES
- 1,2,6,7-Tetrahydro-8H-indeno[5,4-b]furan-8-one
- (S)-2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8yl)ethylamine HCL
- APIXABAN INTERMEDIATES
- 3-morpholino-1-(4-nitrophenyl) -5,6-dihydropyridin-2(1H)-one
- “Ethyl 2-chloro-2-(2-(4-methoxyphenyl) hydrazono) acetate”
- 3-chloro-1-(4-nitrophenyl)-5,6-dihydrop yridin-2(1H)-one
- MARAVIROC INTERMEDIATES
- 4,4-difluorocyclohexylcarboxylic acid
- (S)-methyl 3-amino-3-phenyl propanoate hydrochloride
- “3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octane 4-methylbenzenesulfonate”
